Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Open in API
Filings indexed 1,586 across all filing types
Latest filing 2016-06-13 Declaration of Voting R…
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
8-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes: 1) Entry into a material definitive agreement (an amendment to a supply agreement), 2) Submission of matters to a vote of security holders at the Annual Meeting including detailed voting results, and 3) Other events including insider trading policy and planned sales of shares by executives. The document is not a full financial report like an Annual Report (10-K) or Quarterly Report (IR), nor is it a transcript, proxy statement, or earnings release. It is a regulatory filing reporting material corporate events and voting results. The detailed voting results and description of the Annual Meeting vote indicate it is primarily a Declaration of Voting Results & Voting Rights Announcement. Therefore, the best classification is DVA (Declaration of Voting Results & Voting Rights Announcements). The document length (8128 characters) and detailed vote tabulation support this classification with high confidence.
2016-06-13 English
4 Filing
Director's Dealing
2016-06-03 English
4 Filing
Director's Dealing
2016-05-16 English
10-Q Filing
Interim / Quarterly Report Q1 2016
2016-05-13 English
4 Filing
Director's Dealing
2016-05-10 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release announcing first quarter results for the period ended March 31, 2016. The document includes a press release as an exhibit and states that the information is not deemed "filed" for certain regulatory purposes, indicating it is an initial announcement rather than a full detailed report. The length of the document is 3312 characters, which is relatively short and consistent with an earnings release announcement rather than a full quarterly or annual report. Therefore, this document is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only.
2016-05-10 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.